Literature DB >> 26656682

Bovine Herpesvirus 4 Modulates Its β-1,6-N-Acetylglucosaminyltransferase Activity through Alternative Splicing.

Céline Lété1, Nicolas Markine-Goriaynoff1, Bénédicte Machiels1, Poh-Choo Pang2, Xue Xiao1, Kevin Canis2, Masami Suzuki3, Minoru Fukuda3, Anne Dell2, Stuart M Haslam2, Alain Vanderplasschen1, Laurent Gillet4.   

Abstract

UNLABELLED: Carbohydrates play major roles in host-virus interactions. It is therefore not surprising that, during coevolution with their hosts, viruses have developed sophisticated mechanisms to hijack for their profit different pathways of glycan synthesis. Thus, the Bo17 gene of Bovine herpesvirus 4 (BoHV-4) encodes a homologue of the cellular core 2 protein β-1,6-N-acetylglucosaminyltransferase-mucin type (C2GnT-M), which is a key player for the synthesis of complex O-glycans. Surprisingly, we show in this study that, as opposed to what is observed for the cellular enzyme, two different mRNAs are encoded by the Bo17 gene of all available BoHV-4 strains. While the first one corresponds to the entire coding sequence of the Bo17 gene, the second results from the splicing of a 138-bp intron encoding critical residues of the enzyme. Antibodies generated against the Bo17 C terminus showed that the two forms of Bo17 are expressed in BoHV-4 infected cells, but enzymatic assays revealed that the spliced form is not active. In order to reveal the function of these two forms, we then generated recombinant strains expressing only the long or the short form of Bo17. Although we did not highlight replication differences between these strains, glycomic analyses and lectin neutralization assays confirmed that the splicing of the Bo17 gene gives the potential to BoHV-4 to fine-tune the global level of core 2 branching activity in the infected cell. Altogether, these results suggest the existence of new mechanisms to regulate the activity of glycosyltransferases from the Golgi apparatus. IMPORTANCE: Viruses are masters of adaptation that hijack cellular pathways to allow their growth. Glycans play a central role in many biological processes, and several studies have highlighted mechanisms by which viruses can affect glycosylation. Glycan synthesis is a nontemplate process regulated by the availability of key glycosyltransferases. Interestingly, bovine herpesvirus 4 encodes one such enzyme which is a key enzyme for the synthesis of complex O-glycans. In this study, we show that, in contrast to cellular homologues, this virus has evolved to alternatively express two proteins from this gene. While the first one is enzymatically active, the second results from the alternative splicing of the region encoding the catalytic site of the enzyme. We postulate that this regulatory mechanism could allow the virus to modulate the synthesis of some particular glycans for function at the location and/or the moment of infection.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26656682      PMCID: PMC4734007          DOI: 10.1128/JVI.01722-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

Review 1.  Glycosylation and the immune system.

Authors:  P M Rudd; T Elliott; P Cresswell; I A Wilson; R A Dwek
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

2.  Formation of insoluble oligomers correlates with ST6Gal I stable localization in the golgi.

Authors:  C Chen; J Ma; A Lazic; M Backovic; K J Colley
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

3.  Genome sequence of bovine herpesvirus 4, a bovine Rhadinovirus, and identification of an origin of DNA replication.

Authors:  W Zimmermann; H Broll; B Ehlers; H J Buhk; A Rosenthal; M Goltz
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  A bovine macrophage cell line supports bovine herpesvirus-4 persistent infection.

Authors:  Gaetano Donofrio; Vicky L van Santen
Journal:  J Gen Virol       Date:  2001-05       Impact factor: 3.891

5.  Diverse IgG serum response to novel glycopeptide epitopes detected within immunodominant stretches of Epstein-Barr virus glycoprotein 350/220: diagnostic potential of O-glycopeptide microarrays.

Authors:  Isotta D'Arrigo; Emiliano Cló; Tomas Bergström; Sigvard Olofsson; Ola Blixt
Journal:  Glycoconj J       Date:  2013-01-08       Impact factor: 2.916

6.  Control of O-glycan branch formation. Molecular cloning and characterization of a novel thymus-associated core 2 beta1, 6-n-acetylglucosaminyltransferase.

Authors:  T Schwientek; J C Yeh; S B Levery; B Keck; G Merkx; A G van Kessel; M Fukuda; H Clausen
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

7.  Complete genome sequences of elephant endotheliotropic herpesviruses 1A and 1B determined directly from fatal cases.

Authors:  Gavin S Wilkie; Andrew J Davison; Mick Watson; Karen Kerr; Stephanie Sanderson; Tim Bouts; Falko Steinbach; Akbar Dastjerdi
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

Review 8.  Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design.

Authors:  Max Crispin; Katie J Doores
Journal:  Curr Opin Virol       Date:  2015-03-06       Impact factor: 7.090

9.  A gammaherpesvirus uses alternative splicing to regulate its tropism and its sensitivity to neutralization.

Authors:  Bénédicte Machiels; Philip G Stevenson; Alain Vanderplasschen; Laurent Gillet
Journal:  PLoS Pathog       Date:  2013-10-31       Impact factor: 6.823

10.  A strategy for O-glycoproteomics of enveloped viruses--the O-glycoproteome of herpes simplex virus type 1.

Authors:  Ieva Bagdonaite; Rickard Nordén; Hiren J Joshi; Sally Dabelsteen; Kristina Nyström; Sergey Y Vakhrushev; Sigvard Olofsson; Hans H Wandall
Journal:  PLoS Pathog       Date:  2015-04-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.